Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Nattress C"'
Autor:
Fowler D; UCL Great Ormond Street Institute of Child Health, Zayed Centre for Research, 20 Guilford Street, WC1N 1DZ London, UK., Barisa M; UCL Great Ormond Street Institute of Child Health, Zayed Centre for Research, 20 Guilford Street, WC1N 1DZ London, UK., Southern A; UCL Great Ormond Street Institute of Child Health, Zayed Centre for Research, 20 Guilford Street, WC1N 1DZ London, UK., Nattress C; UCL Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, WC1E 6DD London, UK., Hawkins E; UCL Great Ormond Street Institute of Child Health, Zayed Centre for Research, 20 Guilford Street, WC1N 1DZ London, UK., Vassalou E; UCL Great Ormond Street Institute of Child Health, Zayed Centre for Research, 20 Guilford Street, WC1N 1DZ London, UK., Kanouta A; UCL Great Ormond Street Institute of Child Health, Zayed Centre for Research, 20 Guilford Street, WC1N 1DZ London, UK., Counsell J, Rota E; UCL Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, WC1E 6DD London, UK., Vlckova P; UCL Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, WC1E 6DD London, UK., Draper B; UCL Great Ormond Street Institute of Child Health, Zayed Centre for Research, 20 Guilford Street, WC1N 1DZ London, UK., De Mooij T; UCL Great Ormond Street Institute of Child Health, Zayed Centre for Research, 20 Guilford Street, WC1N 1DZ London, UK., Farkas A; UCL Great Ormond Street Institute of Child Health, Zayed Centre for Research, 20 Guilford Street, WC1N 1DZ London, UK., Brezovjakova H; UCL Great Ormond Street Institute of Child Health, Zayed Centre for Research, 20 Guilford Street, WC1N 1DZ London, UK., Baker AT; UCL Great Ormond Street Institute of Child Health, Zayed Centre for Research, 20 Guilford Street, WC1N 1DZ London, UK., Scotlandi K; IRCCS Istituto Ortopedico Rizzoli, Experimental Oncology Laboratory, Via di Barbiano 1/10, 40136 Bologna Italy., Manara MC; IRCCS Istituto Ortopedico Rizzoli, Experimental Oncology Laboratory, Via di Barbiano 1/10, 40136 Bologna Italy., Tape C; UCL Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, WC1E 6DD London, UK., Chester K; UCL Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, WC1E 6DD London, UK., Anderson J; UCL Great Ormond Street Institute of Child Health, Zayed Centre for Research, 20 Guilford Street, WC1N 1DZ London, UK., Fisher J; UCL Great Ormond Street Institute of Child Health, Zayed Centre for Research, 20 Guilford Street, WC1N 1DZ London, UK.
Publikováno v:
Science translational medicine [Sci Transl Med] 2024 May 29; Vol. 16 (749), pp. eadg9814. Date of Electronic Publication: 2024 May 29.
Autor:
Nattress, C., Bryant, D. J.
Publikováno v:
Active Travel Studies; 2023, Vol. 3 Issue 2, p1-N.PAG, 15p
Autor:
Ramos Zapatero M; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London WC1E 6DD, UK., Tong A; Department of Computer Science, Yale University, New Haven, CT, USA; Department of Computer Science and Operations Research, Université de Montréal, Montreal, QC, Canada; Mila - Quebec AI Institute, Montréal, QC, Canada., Opzoomer JW; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London WC1E 6DD, UK., O'Sullivan R; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London WC1E 6DD, UK., Cardoso Rodriguez F; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London WC1E 6DD, UK., Sufi J; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London WC1E 6DD, UK., Vlckova P; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London WC1E 6DD, UK., Nattress C; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London WC1E 6DD, UK., Qin X; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London WC1E 6DD, UK., Claus J; Phospho Biomedical Animation, The Greenhouse Studio 6, London N17 9QU, UK., Hochhauser D; Drug-DNA Interactions Group, Department of Oncology, University College London Cancer Institute, London WC1E 6DD, UK., Krishnaswamy S; Department of Computer Science, Yale University, New Haven, CT, USA; Department of Genetics, Yale University, New Haven, CT, USA; Program for Computational Biology & Bioinformatics, Yale University, New Haven, CT, USA; Program for Applied Math, Yale University, New Haven, CT, USA; Wu-Tsai Institute, Yale University, New Haven, CT, USA. Electronic address: smita.krishnaswamy@yale.edu., Tape CJ; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London WC1E 6DD, UK. Electronic address: c.tape@ucl.ac.uk.
Publikováno v:
Cell [Cell] 2023 Dec 07; Vol. 186 (25), pp. 5606-5619.e24.
Autor:
Phillips MM; Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK.; Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, UK., Pavlyk I; Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK., Allen M; Center for Tumor Microenvironment, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK., Ghazaly E; Centre for Haemato-Oncology, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK.; Medicines and Healthcare Products Regulatory Agency (MHRA), London, UK., Cutts R; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Carpentier J; Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK., Berry JS; Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK., Nattress C; Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK., Feng S; Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK., Hallden G; Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK., Chelala C; Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK., Bomalaski J; Polaris Pharmaceuticals, Inc., San Diego, CA, 92121, USA., Steele J; Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, UK., Sheaff M; Department of Histopathology, Barts Health NHS Trust, Royal London Hospital, London, E1 1BB, UK., Balkwill F; Center for Tumor Microenvironment, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK., Szlosarek PW; Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK. p.w.szlosarek@qmul.ac.uk.; Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, UK. p.w.szlosarek@qmul.ac.uk.
Publikováno v:
Pharmacological reports : PR [Pharmacol Rep] 2023 Jun; Vol. 75 (3), pp. 753.
Autor:
Phillips MM; Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK.; Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, UK., Pavlyk I; Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK., Allen M; Center for Tumor Microenvironment, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK., Ghazaly E; Centre for Haemato-Oncology, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK.; Medicines and Healthcare Products Regulatory Agency (MHRA), London, UK., Cutts R; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Carpentier J; Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK., Berry JS; Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK., Nattress C; Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK., Feng S; Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK., Hallden G; Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK., Chelala C; Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK., Bomalaski J; Polaris Pharmaceuticals, Inc., San Diego, CA, 92121, USA., Steele J; Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, UK., Sheaff M; Department of Histopathology, Barts Health NHS Trust, Royal London Hospital, London, E1 1BB, UK., Balkwill F; Center for Tumor Microenvironment, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK., Szlosarek PW; Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK. p.w.szlosarek@qmul.ac.uk.; Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, UK. p.w.szlosarek@qmul.ac.uk.
Publikováno v:
Pharmacological reports : PR [Pharmacol Rep] 2023 Jun; Vol. 75 (3), pp. 570-584. Date of Electronic Publication: 2023 Apr 03.
Autor:
Green-Tripp G; Centre for Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Nattress C; Centre for Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London, United Kingdom., Halldén G; Centre for Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
Publikováno v:
Frontiers in molecular biosciences [Front Mol Biosci] 2022 Jun 24; Vol. 9, pp. 901392. Date of Electronic Publication: 2022 Jun 24 (Print Publication: 2022).
Autor:
Rodríguez MDCR; Centre for Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK., Rodríguez IG; OrganoVIR Labs, Department of Medical Microbiology, Amsterdam Institute for Infection and Immunity, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands., Nattress C; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London WC1E 6DD, UK., Qureshi A; Centre for Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK., Halldén G; Centre for Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK.
Publikováno v:
Viruses [Viruses] 2022 May 09; Vol. 14 (5). Date of Electronic Publication: 2022 May 09.
Autor:
Fowler D; UCL Great Ormond Street Institute of Child Health, 20 Guilford St, London WC1N 1DZ, UK., Nattress C; UCL Great Ormond Street Institute of Child Health, 20 Guilford St, London WC1N 1DZ, UK., Navarrete AS; UCL Great Ormond Street Institute of Child Health, 20 Guilford St, London WC1N 1DZ, UK., Barisa M; UCL Great Ormond Street Institute of Child Health, 20 Guilford St, London WC1N 1DZ, UK., Fisher J; UCL Great Ormond Street Institute of Child Health, 20 Guilford St, London WC1N 1DZ, UK.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Nov 29; Vol. 13 (23). Date of Electronic Publication: 2021 Nov 29.
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Stem Cell Research & Therapy. 5/31/2024, Vol. 15 Issue 1, p1-17. 17p.